Disease · HP_0030834
Shoulder pain
6 sourcesdiseases-2026-09-18-0.1.0
Cite this record
ConductScience Library. Shoulder pain. Diseases, record HP_0030834. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/HP_0030834
On this page
Disease
Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.
- Name
- Shoulder pain
- Open Targets ID
- HP_0030834
- Highest stage of its drugs
- Phase 3, for 2 of its 18 drugs, from ClinicalTrials.gov
Source Open Targets
Drugs18
The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Drug | ChEMBL ID | Type | Open Targets' stage | Stage reported by | Reports | Of them trials | Trials shown here | Source |
|---|---|---|---|---|---|---|---|---|
| BOTULINUM TOXIN TYPE A | CHEMBL4297862 | Protein | Phase 3 | ClinicalTrials.gov | 2 | 2 | 2 | Drugs and targets |
| KETOPROFEN | CHEMBL571 | Small molecule | Phase 3 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| LIDOCAINE | CHEMBL79 | Small molecule | Phase 2 | ClinicalTrials.gov | 5 | 5 | 5 | Drugs and targets |
| HYALURONIDASE | CHEMBL1201636 | Enzyme | Phase 2 | ClinicalTrials.gov | 2 | 2 | 2 | Drugs and targets |
| LIDOCAINE HYDROCHLORIDE | CHEMBL1200409 | Small molecule | Phase 2 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| PROPRANOLOL | CHEMBL27 | Small molecule | Phase 2 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| SODIUM THIOSULFATE | CHEMBL2096650 | Small molecule | Phase 2 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| TRIAMCINOLONE | CHEMBL1451 | Small molecule | Phase 2 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| ZOLPIDEM | CHEMBL911 | Small molecule | Phase 1 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| BETAMETHASONE DIPROPIONATE | CHEMBL1200384 | Small molecule | Unknown | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
1 to 10 of 18
See all 18 drugsTargets19
The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.
| Target | Protein | Its drugs that act on it | Mechanisms | Highest stage of those drugs | Gene in Genes | Source |
|---|---|---|---|---|---|---|
| NR3C1 | Glucocorticoid receptor | 5 | Glucocorticoid receptor agonist | Phase 2 | https://conductscience.org/library/genes/2908 | Drugs and targets |
| SCN4A | Sodium channel alpha subunit | 4 | Sodium channel alpha subunit blocker; Sodium channel protein type IV alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6329 | Drugs and targets |
| SCN10A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6336 | Drugs and targets |
| SCN11A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/11280 | Drugs and targets |
| SCN1A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6323 | Drugs and targets |
| SCN2A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6326 | Drugs and targets |
| SCN3A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6328 | Drugs and targets |
| SCN5A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6331 | Drugs and targets |
| SCN7A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6332 | Drugs and targets |
| SCN8A | Sodium channel alpha subunit | 3 | Sodium channel alpha subunit blocker | Phase 2 | https://conductscience.org/library/genes/6334 | Drugs and targets |
1 to 10 of 19
See all 19 targetsTrials18
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.
| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02620579 | Biopsychosocial Influence on Shoulder Pain | Phase 2 | 264 | 2023-01-13 | Shoulder Pain | PROPRANOLOL | Its record names the disease | ClinicalTrials.gov |
| NCT00597766 | Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain | Phase 2 | 28 | 2017-12-13 | Shoulder Pain | TRIAMCINOLONE | Its record names the disease | ClinicalTrials.gov |
| NCT00661089 | Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity | Not applicable | 21 | 2012-02-06 | Post-stroke Shoulder Pain and Spasticity | BOTULINUM TOXIN TYPE A | Its record names the disease | ClinicalTrials.gov |
| NCT00680472 | HKT-500 in Adult Patients With Shoulder Pain | Phase 3 | 368 | Pain | KETOPROFEN | Its record names the disease | ClinicalTrials.gov | |
| NCT04737993 | Pulsed Radiofrequency of Suprascapular Nerve and Shoulder Joint for Chronic Shoulder Pain | Not applicable | 150 | Chronic Shoulder Pain | LIDOCAINE | Its record names the disease | ClinicalTrials.gov | |
| NCT01393925 | Effect of Parecoxib on Postoperative Shoulder Pain After Gynecological Laparoscopy. | Not applicable | 126 | Anti-Inflammatory Agents, Non-Steroidal, Pain, Postoperative, Laparoscopy | PARECOXIB | Its record names the disease | ClinicalTrials.gov | |
| NCT03269760 | Multimodal Sleep Pathway for Shoulder Arthroplasty | Phase 1 | 122 | Sleep Disturbance, Shoulder Arthritis, Arthroplasty Complications, Perioperative/Postoperative Complications | ZOLPIDEM | Its record names the disease | ClinicalTrials.gov | |
| NCT04251832 | Efficacy of Sodium Thiosulfate in Shoulder Pain in Calcific Tendinitis of the Rotator Cuff | Phase 2 | 80 | Sodium Thiosulfate, Calcific Tendinitis, Shoulder Pain | SODIUM THIOSULFATE | Its record names the disease | ClinicalTrials.gov | |
| NCT06718413 | Myofascial Dysfunction in Post Stroke Shoulder Pain | Phase 2 | 68 | Stroke | HYALURONIDASE | Its record names the disease | ClinicalTrials.gov | |
| NCT05381389 | Onset and Recovery of Ultrasound Guided Out-of-plane Versus In-plane Interscalene Block in Arthroscopic Shoulder Surgery | Not applicable | 60 | Analgesia | BUPIVACAINE HYDROCHLORIDE | Its record names the disease | ClinicalTrials.gov |
1 to 10 of 18
See all 18 trialsComparisons in its trials1
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial |
|---|---|---|---|---|
| onabotulinumtoxinA Injection vs Saline Injection: serious adverse events | 1 of 10 | 4 of 11 | 21 | NCT00661089 |
Source Trial comparisons
Papers from its trials9
The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Data dates
The date of each source this release read.
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this disease from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/diseases/v1/HP_0030834
GET https://conductscience.org/api/diseases/v1/HP_0030834/drugs